NCT06960655Enrolling by invitation
Improving Lipid Optimization Quality and Treatment Options in ASCVD
Source: ClinicalTrials.gov · Last updated 18 May 2026
Brief summary (registry, in English)
The goal of this project is to study different approaches to improve the utilization of guideline directed medicines to lower cholesterol in patients with or at high risk of atherosclerosis (cholesterol buildup in the arteries).
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 29 Apr 2025
- Start date
- 14 Oct 2025
- Primary completion date
- 30 Nov 2026
- Lead sponsor
- Brigham and Women's Hospital
- Diseases
- Familial hypercholesterolaemia
- NCT number
- NCT06960655
What you commit to
- Study type: Interventional
- Planned participants: 300
- From 14 Oct 2025 to the primary completion date, 30 Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Advanced dementia
Other
- No PCP, cardiologist, endocrinologist, or nephrologist at MGB
- ESRD on dialysis
- Enrolled in a hospice program
Who the study is looking for
- \>18 years old and \<=95 years old
- Established Atherosclerotic Cardiovascular Disease
- Diabetes
- Possible Familial Hypercholesterolemia (FH)
- High-Risk Primary Prevention
Age in the registry: 18 years to 95 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Brigham and Women's Hospital Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.